AMERICAN INTERNATIONAL GROUP, INC. - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$99,000
-57.1%
79,599
+5.9%
0.00%
-100.0%
Q1 2017$231,000
-19.2%
75,158
+7.1%
0.00%0.0%
Q4 2016$286,000
-99.9%
70,183
-0.3%
0.00%
-50.0%
Q3 2016$446,811,000
+18.0%
70,364
+0.2%
0.00%0.0%
Q2 2016$378,685,000
-29.7%
70,257
+9.0%
0.00%0.0%
Q1 2016$539,000,000
+5.9%
64,4410.0%0.00%0.0%
Q4 2015$509,000,000
+92614.0%
64,441
-0.2%
0.00%0.0%
Q3 2015$549,000
-99.9%
64,553
+0.1%
0.00%
-33.3%
Q2 2015$797,246,000
+8.7%
64,476
+4.4%
0.00%0.0%
Q1 2015$733,388,000
+5.1%
61,7330.0%0.00%0.0%
Q4 2014$697,583,000
+21.5%
61,733
-5.6%
0.00%0.0%
Q3 2014$574,001,000
+22.6%
65,376
+1.8%
0.00%
+50.0%
Q2 2014$468,186,000
+39.3%
64,223
-3.7%
0.00%0.0%
Q1 2014$336,188,000
-3.3%
66,704
+2.4%
0.00%0.0%
Q4 2013$347,764,000
+47.8%
65,126
+5.2%
0.00%
+100.0%
Q3 2013$235,248,000
+233.7%
61,910
+491.1%
0.00%
Q2 2013$70,490,00010,4740.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders